Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
about
beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.Pharmacokinetics of LY163892 in infants and children.Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemLoracarbef: a new orally administered carbacephem antibiotic.
P2860
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@en
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@nl
type
label
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@en
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@nl
prefLabel
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@en
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@nl
P2860
P356
P1476
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
@en
P2093
P2860
P304
P356
10.1007/BF02014248
P577
1987-10-01T00:00:00Z